Save time and money with
Med Tech Market Research

MedTech Business intelligence
supplied through Trade Tracker, Research and Markets and GlobalData

Biotechnology

Nanobiotechnology
Nanobiotechnology, an integration of physical sciences, molecular engineering, biology, chemistry and biotechnology holds considerable promise of advances in pharmaceuticals and healthcare. The report starts with an introduction to various techniques and materials that are relevant to nanobiotechnology. Application in life sciences research, particularly at the cell level sets the stage for role of nanobiotechnology in healthcare in subsequent chapters. more ...

World Pharmaceutical and Biopharmaceutical Market
2010-2015 (Pipeline Analysis of the Top 50 Companies)
This report is the result of a detailed analysis of the late stage R&D pipeline of the 50 top companies in pharmaceuticals, the companies that produce the lion's share of revenues. While the report looks at the entire pipeline to 2015, a key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has transitioned the pharmaceutical industry to biopharmaceuticals in less than a decade. August 2010

Top 10 Biotech Companies. Market Outlook, 2008-2023
The global biotech drug market was worth over $75bn in 2007, with double-figure growth noticeably higher that that of the overall pharmaceutical market. This report will help you to understand those developments and their significance. That report provides valuable commercial information on this exciting industry that no healthcare company should ignore. read more ...

Biomarkers: The Future of Next-Generation Drug R&D
This report analyzes the hot global market for biomarkers and related assays or tests used in drug R&D. The study reviews this dynamic market by looking at drug research and development spending trends, M&As, alliances, major diseases, applications, tools, technologies, products and services. This report suggests the future direction of the market for biomarkers and related '-omic' or pharmacogenomic (PGx) assays or tests used in the next-generation of drug R&D. This study sizes the world market and growth rate of biomarkers and assays for drug R&D spending to 2012. Read more ...

RNA interference markets
Since its discovery, the naturally occurring RNA (ribonucleic acid) interference effect has been acclaimed as the most exciting technical breakthrough in biological research in the last decade. Some industry analysts predict that RNA interference (RNAi) may even surpass PCR as a top technology. Read more ...

Report: Molecular Diagnostics. Technologies, Markets and Companies
This best-selling report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. Aimed at chief executives and chief development officers, it is the most comprehensive and up-to-date one-stop source of information on technical and commercial aspects of molecular diagnostics. It includes profiles of 250 companies more ...

To top